首页> 外文期刊>BMC Infectious Diseases >Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride
【24h】

Proposed phase 2/ step 2 in-vitro test on basis of EN 14561 for standardised testing of the wound antiseptics PVP-iodine, chlorhexidine digluconate, polihexanide and octenidine dihydrochloride

机译:提出的阶段2 /步骤2基于EN 14561的体外试验,用于标准化伤口防腐剂PVP-碘,氯己定Digluconate,polihexide和八苯胺二盐酸盐的标准测试

获取原文
           

摘要

Background Currently, there is no agreed standard for exploring the antimicrobial activity of wound antiseptics in a phase 2/ step 2 test protocol. In the present study, a standardised in-vitro test is proposed, which allows to test potential antiseptics in a more realistically simulation of conditions found in wounds as in a suspension test. Furthermore, factors potentially influencing test results such as type of materials used as test carrier or various compositions of organic soil challenge were investigated in detail. Methods This proposed phase 2/ step 2 test method was modified on basis of the EN 14561 by drying the microbial test suspension on a metal carrier for 1?h, overlaying the test wound antiseptic, washing-off, neutralization, and dispersion at serial dilutions at the end of the required exposure time yielded reproducible, consistent test results. Results The difference between the rapid onset of the antiseptic effect of PVP-I and the delayed onset especially of polihexanide was apparent. Among surface-active antimicrobial compounds, octenidine was more effective than chlorhexidine digluconate and polihexanide, with some differences depending on the test organisms. However, octenidine and PVP-I were approximately equivalent in efficiency and microbial spectrum, while polihexanide required longer exposure times or higher concentrations for a comparable antimicrobial efficacy. Conclusion Overall, this method allowed testing and comparing differ liquid and gel based antimicrobial compounds in a standardised setting.
机译:背景技术目前,在第2/步骤2测试方案中没有商定探索伤口抗菌剂的抗微生物活性标准。在本研究中,提出了一种标准化的体外试验,其允许在更现实地模拟伤口中的病症中测试潜在的抗菌剂,如悬浮试验中的伤口中发现。此外,详细研究了潜在影响测试结果,例如用作试验载体或各种有机土攻击组成的材料类型的因素。方法通过将微生物试验悬浮液在金属载体上干燥1〜H,覆盖试验伤口抗菌性,洗涤,中和和在连续稀释时,通过将微生物试验悬浮液进行干燥,根据EN 14561进行修复该阶段2 /步骤2测试方法。在所需的暴露时间结束时,产生可重复的,一致的测试结果。结果PVP-I的抗菌作用的快速发作与延迟发作的差异是显而易见的。在表面活性抗微生物化合物中,辛苯胺比氯己定量曲琥珀酸酯和波希塞纳德更有效,这取决于试验生物的差异。然而,八苯胺丁和PVP-1在效率和微生物谱中大致相当,而Palihexany需要更长的暴露时间或更高的浓度,以获得可比较的抗微生物功效。结论总体而言,该方法允许在标准化设置中进行测试和比较基于液体和凝胶的凝胶抗微生物化合物。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号